Riskpilot← Back to searchSign inGet full accessPACURAMED AS
ASActiveOrg 993577839Brynsveien 13, 0667 OsloTemporary employment agency activities and other human resource provisions · NACE 7820Est. 2009649 employeeswww.pacuramed.no
Revenue 2024
NOK 151M
-1% vs 2023
EBITDA margin
0.9%
-59% vs 2023
Equity ratio
2.2%
Financial strength
Net profit 2024
NOK 1M
-54% vs 2023
| Revenue | NOK 151M | -1% |
| EBITDA | NOK 1,3M | -59% |
| Net profit | NOK 1M | -54% |
| Total assets | NOK 34,4M | -7% |
| Equity | NOK 747K | -48% |
| Employees | 649 | — |
Legal name
PACURAMED AS
Org number
993577839
Legal form
Aksjeselskap
NACE code
7820 · Temporary employment agency activities and other human resource provisions
Founded
11. februar 2009
Share capital
NOK 100 000
Employees
649 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Kjøp, salg, utvikling og drift av andre selskap, bemanningstjenester, rådgiving, samt alt som naturlig hører inn under dette.
Address
Brynsveien 13, 0667 Oslo
Phone
+4723231515
Email
post@reflekt.no
Website
www.pacuramed.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 94 129 | 114 272 | 136 720 | 153 076 | 150 997 |
| Staff expenses | −82 929 | −95 386 | −118 231 | −136 889 | −137 316 |
| EBITDA | 7 252 | 12 265 | 10 339 | 3 270 | 1 346 |
| Depreciation & amort. | −23 | −9 | −0 | −0 | −0 |
| EBIT | 7 229 | 12 256 | 10 339 | 3 270 | 1 346 |
| Net financials | −807 | −1 407 | −1 807 | −506 | −35 |
| Profit before tax | 6 422 | 10 849 | 8 532 | 2 764 | 1 311 |
| Tax | 1 417 | 2 388 | 1 878 | 609 | 310 |
| Net profit | 5 005 | 8 461 | 6 654 | 2 155 | 1 001 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 35 017 | 63 438 | 60 028 | 36 966 | 34 374 |
| Equity | 393 | 413 | 433 | 1 423 | 747 |
| Long-term debt | 0 | 10 823 | 0 | 0 | 0 |
| Short-term debt | 34 624 | 52 203 | 59 595 | 35 543 | 33 627 |
| Total debt | 34 624 | 63 025 | 59 595 | 35 543 | 33 627 |
EBITDA margin
0.9%
This company
15.8%
Market median
-94% vs market
20202024
Equity ratio
2.2%
This company
38.2%
Market median
-94% vs market
20202024
Return on equity
134.0%
This company
18.4%
Market median
+628% vs market
20202024
Net profit margin
0.7%
This company
8.1%
Market median
-91% vs market
20202024
Asset turnover
4.39×
This company
1.12×
Market median
+292% vs market
20202024
Debt / equity
45.01×
This company
0.62×
Market median
-7160% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PE Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (2) | ||
KG Chief Executive Officer | Chief Executive Officer | 2016 – 2022 |
TS Chief Executive Officer | Chief Executive Officer | 2023 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2025 | |
| Former (1) | ||
| Chairman | 2023 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 | |
| Individual | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Arano Group Scandinavia As
PACURAMED AS Board members of PACURAMED AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Egil Aas | Chief Executive Officer | 0 companies |
| Katharine Gude | Chief Executive Officer | 0 companies |
| Torbjørn Sørlie | Chief Executive Officer | 0 companies |
| Alexander Gusev | Chairman | 0 companies |
| Christoph Tarcisio Gerschütz | Chairman | 0 companies |